BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21429047)

  • 1. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid.
    Uemura T; Schaefer E; Hollenbeak CS; Khan A; Kadry Z
    Transpl Int; 2011 Jul; 24(7):640-50. PubMed ID: 21429047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
    Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
    J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
    Lischke R; Simonek J; Davidová R; Schützner J; Stolz AJ; Vojácek J; Burkert J; Pafko P
    Transplant Proc; 2007; 39(1):205-12. PubMed ID: 17275507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab.
    Burton CM; Andersen CB; Jensen AS; Iversen M; Milman N; Boesgaard S; Arendrup H; Eliasen K; Carlsen J
    J Heart Lung Transplant; 2006 Jun; 25(6):638-47. PubMed ID: 16730569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
    Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
    Cai J; Terasaki PI
    Transplantation; 2010 Dec; 90(12):1511-5. PubMed ID: 21057388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function.
    Emre S; Gondolesi G; Polat K; Ben-Haim M; Artis T; Fishbein TM; Sheiner PA; Kim-Schluger L; Schwartz ME; Miller CM
    Liver Transpl; 2001 Mar; 7(3):220-5. PubMed ID: 11244163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
    Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
    Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.
    van de Linde P; Vd Boog PJ; Tysma OM; Elliott JF; Roelen DL; Claas FH; de Fijter JW; Roep BO
    Clin Exp Immunol; 2007 Jul; 149(1):56-62. PubMed ID: 17459076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study.
    Klintmalm GB; Washburn WK; Rudich SM; Heffron TG; Teperman LW; Fasola C; Eckhoff DE; Netto GJ; Katz E
    Liver Transpl; 2007 Nov; 13(11):1521-31. PubMed ID: 17969201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma.
    Suh MY; Wang K; Gutweiler JR; Misra MV; Krawczuk LE; Jenkins RL; Lillehei CW; Jonas MM; Kim HB
    J Pediatr Surg; 2008 Jun; 43(6):1148-52. PubMed ID: 18558198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas transplantation in the United States as reported to the United Network for Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry.
    Sutherland DE; Gruessner A
    Clin Transpl; 1995; ():49-67. PubMed ID: 8794254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
    Morris JA; Hanson JE; Steffen BJ; Chu AH; Chi-Burris KS; Gotz VP; Gordon RD
    Clin Transplant; 2005 Jun; 19(3):340-5. PubMed ID: 15877795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation.
    Ciancio G; Gaynor JJ; Sageshima J; Guerra G; Zarak A; Roth D; Brown R; Kupin W; Chen L; Hanson L; Tueros L; Ruiz P; Livingstone AS; Burke GW
    Transplantation; 2011 Dec; 92(12):1348-57. PubMed ID: 22027927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
    Tector AJ; Fridell JA; Mangus RS; Shah A; Milgrom M; Kwo P; Chalasani N; Yoo H; Rouch D; Liangpunsakul S; Herring S; Lumeng L
    Liver Transpl; 2004 Mar; 10(3):404-7. PubMed ID: 15004768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I; Hsaiky L; Brown K; Abouljoud M
    Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
    Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation.
    Mullen JC; Oreopoulos A; Lien DC; Bentley MJ; Modry DL; Stewart K; Winton TL; Jackson K; Doucette K; Preiksaitis J; Halloran PF
    J Heart Lung Transplant; 2007 May; 26(5):504-10. PubMed ID: 17449421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.